Andrew M E, Karupiah G, Boyle D B, Blanden R V, Mullbacher A, Ramshaw I A, Coupar B E
CSIRO Australian Animal Health Laboratory, Geelong, Australia.
Microb Pathog. 1991 May;10(5):363-71. doi: 10.1016/0882-4010(91)90081-k.
Vaccinia virus that expressed interleukin 2 (IL 2) was cleared from immunodeficient irradiated mice more efficiently than virus that did not express interleukin 2. These results extend the previously observed protection from nude mice to another model of immunodeficiency. No antibody or cytotoxic T lymphocyte response could be detected in sublethally irradiated mice that had been inoculated with IL 2-expressing vaccinia virus, but levels of splenic natural killer cell activity were elevated. Sublethally irradiated mice that had recovered from IL 2-plus hemagglutinin-expressing vaccinia virus were partially protected against both influenza virus and vaccinia virus. These results indicate that vaccinia virus-expressed IL 2 mediates clearance of primary viral infection via a mechanism that does not involve antibody or cytotoxic T lymphocytes. They also indicate that inclusion of lymphokine genes in live recombinant viral vaccine vectors may increase vaccine safety.
表达白细胞介素2(IL-2)的痘苗病毒从免疫缺陷的辐照小鼠体内清除的效率比不表达白细胞介素2的病毒更高。这些结果将先前在裸鼠中观察到的保护作用扩展到了另一种免疫缺陷模型。在接种了表达IL-2的痘苗病毒的亚致死辐照小鼠中,未检测到抗体或细胞毒性T淋巴细胞反应,但脾脏自然杀伤细胞活性水平有所升高。从表达IL-2加血凝素的痘苗病毒感染中恢复的亚致死辐照小鼠对流感病毒和痘苗病毒都有部分保护作用。这些结果表明,痘苗病毒表达的IL-2通过一种不涉及抗体或细胞毒性T淋巴细胞的机制介导原发性病毒感染的清除。它们还表明,在活重组病毒疫苗载体中包含淋巴因子基因可能会提高疫苗的安全性。